Your browser doesn't support javascript.
loading
Nogo-A is secreted in extracellular vesicles, occurs in blood and can influence vascular permeability.
Rust, Ruslan; Holm, Mea M; Egger, Matteo; Weinmann, Oliver; van Rossum, Daniёlle; Walter, Fruzsina R; Santa-Maria, Ana Raquel; Grönnert, Lisa; Maurer, Michael A; Kraler, Simon; Akhmedov, Alexander; Cideciyan, Rose; Lüscher, Thomas F; Deli, Maria A; Herrmann, Inge K; Schwab, Martin E.
Afiliação
  • Rust R; Brain Research Institute, University of Zürich, Switzerland.
  • Holm MM; Department of Health Sciences and Technology, ETH Zürich, Switzerland.
  • Egger M; Institute for Regenerative Medicine (IREM), University of Zurich, Switzerland.
  • Weinmann O; Brain Research Institute, University of Zürich, Switzerland.
  • van Rossum D; Department of Health Sciences and Technology, ETH Zürich, Switzerland.
  • Walter FR; Department of Health Sciences and Technology, ETH Zürich, Switzerland.
  • Santa-Maria AR; Brain Research Institute, University of Zürich, Switzerland.
  • Grönnert L; Department of Translational Neuroscience, UMC Utrecht, Netherlands.
  • Maurer MA; Biological Barriers Research Group, ELKH Biological Research Centre, Szeged, Hungary.
  • Kraler S; Biological Barriers Research Group, ELKH Biological Research Centre, Szeged, Hungary.
  • Akhmedov A; Brain Research Institute, University of Zürich, Switzerland.
  • Cideciyan R; Brain Research Institute, University of Zürich, Switzerland.
  • Lüscher TF; Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Deli MA; Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Herrmann IK; Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Schwab ME; Center for Molecular Cardiology, University of Zurich, Switzerland.
J Cereb Blood Flow Metab ; : 271678X231216270, 2023 Nov 24.
Article em En | MEDLINE | ID: mdl-38000040
ABSTRACT
Nogo-A is a transmembrane protein with multiple functions in the central nervous system (CNS), including restriction of neurite growth and synaptic plasticity. Thus far, Nogo-A has been predominantly considered a cell contact-dependent ligand signaling via cell surface receptors. Here, we show that Nogo-A can be secreted by cultured cells of neuronal and glial origin in association with extracellular vesicles (EVs). Neuron- and oligodendrocyte-derived Nogo-A containing EVs inhibited fibroblast spreading, and this effect was partially reversed by Nogo-A receptor S1PR2 blockage. EVs purified from HEK cells only inhibited fibroblast spreading upon Nogo-A over-expression. Nogo-A-containing EVs were found in vivo in the blood of healthy mice and rats, as well as in human plasma. Blood Nogo-A concentrations were elevated after acute stroke lesions in mice and rats. Nogo-A active peptides decreased barrier integrity in an in vitro blood-brain barrier model. Stroked mice showed increased dye permeability in peripheral organs when tested 2 weeks after injury. In the Miles assay, an in vivo test to assess leakage of the skin vasculature, a Nogo-A active peptide increased dye permeability. These findings suggest that blood borne, possibly EV-associated Nogo-A could exert long-range regulatory actions on vascular permeability.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article